Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis

医学 前列腺癌 前列腺 荟萃分析 置信区间 活检 磁共振成像 分级(工程) 放射科 内科学 前列腺活检 癌症 土木工程 工程类
作者
Niranjan Sathianathen,Altan Omer,Eli Harriss,Lucy Davies,Veeru Kasivisvanathan,Shonit Punwani,Caroline M. Moore,Christof Kastner,Tristan Barrett,Roderick CN van den Bergh,Ben Eddy,Fergus Gleeson,Ruth E. Macpherson,Richard J. Bryant,James W.F. Catto,Declan G. Murphy,Freddie C. Hamdy,Hashim U. Ahmed,Alastair Lamb
出处
期刊:European Urology [Elsevier BV]
卷期号:78 (3): 402-414 被引量:336
标识
DOI:10.1016/j.eururo.2020.03.048
摘要

: Prebiopsy multiparametric magnetic resonance imaging (mpMRI) is increasingly used in prostate cancer diagnosis. The reported negative predictive value (NPV) of mpMRI is used by some clinicians to aid in decision making about whether or not to proceed to biopsy. : We aim to perform a contemporary systematic review that reflects the latest literature on optimal mpMRI techniques and scoring systems to update the NPV of mpMRI for clinically significant prostate cancer (csPCa). : We conducted a systematic literature search and included studies from 2016 to September 4, 2019, which assessed the NPV of mpMRI for csPCa, using biopsy or clinical follow-up as the reference standard. To ensure that studies included in this analysis reflect contemporary practice, we only included studies in which mpMRI findings were interpreted according to the Prostate Imaging Reporting and Data System (PIRADS) or similar Likert grading system. We define negative mpMRI as either (1) PIRADS/Likert 1–2 or (2) PIRADS/Likert 1–3; csPCa was defined as either (1) Gleason grade group ≥2 or (2) Gleason grade group ≥3. We calculated NPV separately for each combination of negative mpMRI and csPCa. : A total of 42 studies with 7321 patients met our inclusion criteria and were included for analysis. Using definition (1) for negative mpMRI and csPCa, the pooled NPV for biopsy-naïve men was 90.8% (95% confidence interval [CI] 88.1–93.1%). When defining csPCa using definition (2), the NPV for csPCa was 97.1% (95% CI 94.9–98.7%). Calculation of the pooled NPV using definition (2) for negative mpMRI and definition (1) for csPCa yielded the following: 86.8% (95% CI 80.1–92.4%). Using definition (2) for both negative mpMRI and csPCa, the pooled NPV from two studies was 96.1% (95% CI 93.4–98.2%). : Multiparametric MRI of the prostate is generally an accurate test for ruling out csPCa. However, we observed heterogeneity in the NPV estimates, and local institutional data should form the basis of decision making if available. : The negative predictive values should assist in decision making for clinicians considering not proceeding to biopsy in men with elevated age-specific prostate-specific antigen and multiparametric magnetic resonance imaging reported as negative (or equivocal) on Prostate Imaging Reporting and Data System/Likert scoring. Some 7–10% of men, depending on the setting, will miss a diagnosis of clinically significant cancer if they do not proceed to biopsy. Given the institutional variation in results, it is of upmost importance to base decision making on local data if available.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Tqun完成签到,获得积分10
刚刚
you完成签到 ,获得积分10
1秒前
lfy完成签到,获得积分10
1秒前
小毛竹完成签到 ,获得积分10
5秒前
DW的应助被WinStar采纳,获得10
5秒前
智文完成签到 ,获得积分10
7秒前
8秒前
从容棉花糖完成签到,获得积分10
9秒前
Akim的应助被俏皮诺言采纳,获得10
11秒前
junjun2011完成签到 ,获得积分10
11秒前
烟花弥漫完成签到 ,获得积分10
13秒前
明朗完成签到 ,获得积分0
14秒前
about发布了新的文献求助10
14秒前
默默白桃完成签到 ,获得积分10
16秒前
我爱自由民权完成签到,获得积分10
18秒前
阳光雅蕊完成签到,获得积分10
18秒前
hugefrog完成签到,获得积分10
20秒前
wxf666完成签到 ,获得积分10
20秒前
HelloBOB完成签到 ,获得积分10
22秒前
PORCO完成签到,获得积分10
27秒前
英勇雅琴完成签到 ,获得积分10
27秒前
dingo完成签到,获得积分10
30秒前
阿南完成签到 ,获得积分0
31秒前
朴素傲松完成签到,获得积分10
31秒前
追寻微笑完成签到 ,获得积分10
32秒前
taotao完成签到 ,获得积分10
32秒前
zilicai的应助被十二采纳,获得20
32秒前
duktig完成签到 ,获得积分10
33秒前
hooqueen完成签到 ,获得积分10
33秒前
about完成签到,获得积分10
34秒前
韩寒123完成签到,获得积分10
35秒前
特特特特特完成签到,获得积分10
37秒前
bobinson完成签到,获得积分10
37秒前
乐观的星月完成签到 ,获得积分0
41秒前
Hello的应助被liugm采纳,获得10
43秒前
小菀儿完成签到 ,获得积分10
44秒前
Royzeng完成签到 ,获得积分10
48秒前
止咳宝完成签到,获得积分10
48秒前
科研通AI6.3的应助被单身的紊采纳,获得10
50秒前
JonyJie完成签到,获得积分10
50秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190389
求助须知:如何正确求助?哪些是违规求助? 9577468
关于积分的说明 21852623
捐赠科研通 7789041
什么是DOI,文献DOI怎么找? 3436369
关于科研通互助平台的介绍 2560180
邀请新用户注册赠送积分活动 2482995